A small compound targeting prohibitin with potential interest for cognitive deficit rescue in aging mice and tau pathology treatment

 

Guyot, A., Leuxe, C., Disdier, C. et al.

Scientific Reports 2020, vol:10, 1143 doi: 10.1038/s41598-020-57560-3

Abstract

Neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, are characterized by increased protein aggregation in the brain, progressive neuronal loss, increased inflammation, and neurogenesis impairment. We analyzed the effects of a new purine derivative drug, PDD005, in attenuating mechanisms involved in the pathogenesis of neurodegenerative diseases, using both in vivo and in vitro models. We show that PDD005 is distributed to the brain and can rescue cognitive deficits associated with aging in mice. Treatment with PDD005 prevents impairment of neurogenesis by increasing sex-determining region Y-box 2, nestin, and also enhances synaptic function through upregulation of synaptophysin and postsynaptic density protein 95. PDD005 treatment also reduced neuro-inflammation by decreasing interleukin-1β expression, activation of astrocytes, and microglia. We identified prohibitin as a potential target in mediating the therapeutic effects of PDD005 for the treatment of cognitive deficit in aging mice. Additionally, in the current study, glycogen synthase kinase appears to attenuate tau pathology.

View Publication

Topics: Neurodegenerative diseases, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

Previous Article
Quantitative thermophoretic study of disease-related protein aggregates
Quantitative thermophoretic study of disease-related protein aggregates

Up next
The voltage-dependent anion channel 1 mediates amyloid ß toxicity and represents a potential target for AD therapy
The voltage-dependent anion channel 1 mediates amyloid ß toxicity and represents a potential target for AD therapy

Characterize the molecular mechanisms of neurodegenerative diseases

Learn how
×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!